Our Field Applications Scientist Danilo La Terra recently presented some of the Simoa® highlights from AD/PD™ 2022. Watch the recording to hear about how phosphorylated Tau 181, GFAP, NfL and others are being measured in blood to transform the way we identify patients with Alzheimer‘s Disease. We also covered how Simoa® ultra-sensitive assays work, as well as the performance of our key assays for Alzheimer’s Disease, including phosphorylated Tau and our multiplex assays. Most importantly, we answered questions from the audience on how a neuro-toolbox on Simoa® can help your research!

Recording link (gated)